157 related articles for article (PubMed ID: 31880256)
1. Assessment of Expression of Homeobox A5 in Endometrial Cancer on the mRNA and Protein Level.
Dziobek K; Oplawski M; Zmarzły N; Gabarek BO; Kiełbasiński R; Kiełbasiński K; Kieszkowski P; Talkowski K; Boroń D
Curr Pharm Biotechnol; 2020; 21(7):635-641. PubMed ID: 31880256
[TBL] [Abstract][Full Text] [Related]
2. Expression Profile of Endoglin in Different Grades of Endometrial Cancer.
Opławski M; Dziobek K; Adwent I; Dąbruś D; Grabarek B; Zmarzły N; Plewka A; Boroń D
Curr Pharm Biotechnol; 2018; 19(12):990-995. PubMed ID: 30479213
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Changes in the Expression Pattern of EDIL3 in Different Grades of Endometrial Cancer.
Oplawski M; Dziobek K; Zmarzły N; Grabarek B; Tomala B; Leśniak E; Adwent I; Januszyk P; Dąbruś D; Boroń D
Curr Pharm Biotechnol; 2019; 20(6):483-488. PubMed ID: 30961491
[TBL] [Abstract][Full Text] [Related]
4. Identification of a gene expression profile associated with the regulation of angiogenesis in endometrial cancer.
Opławski M; Michalski M; Witek A; Michalski B; Zmarzły N; Jęda-Golonka A; Styblińska M; Gola J; Kasprzyk-Żyszczyńska M; Mazurek U; Plewka A
Mol Med Rep; 2017 Sep; 16(3):2547-2555. PubMed ID: 28656251
[TBL] [Abstract][Full Text] [Related]
5. Expression Profile of VEGF-C, VEGF-D, and VEGFR-3 in Different Grades of Endometrial Cancer.
Oplawski M; Dziobek K; Zmarzły N; Grabarek B; Halski T; Januszyk P; Kuś-Kierach A; Adwent I; Dąbruś D; Kiełbasiński K; Boroń D
Curr Pharm Biotechnol; 2019; 20(12):1004-1010. PubMed ID: 31333122
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of Homeobox A5 gene in nonsmall cell lung cancer and its relationship with clinicopathological features.
Kim DS; Kim MJ; Lee JY; Lee SM; Choi JY; Yoon GS; Na YK; Hong HS; Kim SG; Choi JE; Lee SY; Park JY
Mol Carcinog; 2009 Dec; 48(12):1109-15. PubMed ID: 19554572
[TBL] [Abstract][Full Text] [Related]
7. Changes in the Expression Profile of VEGF-A, VEGF-B, VEGFR-1, VEGFR-2 in Different Grades of Endometrial Cancer.
Dziobek K; Opławski M; Grabarek BO; Zmarzły N; Tomala B; Halski T; Leśniak E; Januszyk K; Brus R; Kiełbasiński R; Boroń D
Curr Pharm Biotechnol; 2019; 20(11):955-963. PubMed ID: 31322068
[TBL] [Abstract][Full Text] [Related]
8. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease.
Singh M; Spoelstra NS; Jean A; Howe E; Torkko KC; Clark HR; Darling DS; Shroyer KR; Horwitz KB; Broaddus RR; Richer JK
Mod Pathol; 2008 Jul; 21(7):912-23. PubMed ID: 18487993
[TBL] [Abstract][Full Text] [Related]
9. Expression of Semaphorin 3B (SEMA3B) in Various Grades of Endometrial Cancer.
Dziobek K; Opławski M; Grabarek B; Zmarzły N; Januszyk P; Adwent I; Dąbruś D; Leśniak E; Kiełbasiński R; Kieszkowski P; Boroń D
Med Sci Monit; 2019 Jun; 25():4569-4574. PubMed ID: 31217417
[TBL] [Abstract][Full Text] [Related]
10. Changes in Expression Pattern of SEMA3F Depending on Endometrial Cancer Grade - Pilot Study.
Dziobek K; Opławski M; Grabarek B; Zmarzły N; Kiełbasiński R; Leśniak E; Januszyk P; Januszyk K; Adwent I; Dąbruś D; Kieszkowski P; Kiełbasiński K; Kuś-Kierach A; Boroń D
Curr Pharm Biotechnol; 2019; 20(9):727-732. PubMed ID: 31215376
[TBL] [Abstract][Full Text] [Related]
11. Expression of NRP-1 and NRP-2 in Endometrial Cancer.
Oplawski M; Dziobek K; Grabarek B; Zmarzły N; Dąbruś D; Januszyk P; Brus R; Tomala B; Boroń D
Curr Pharm Biotechnol; 2019; 20(3):254-260. PubMed ID: 30806307
[TBL] [Abstract][Full Text] [Related]
12. Is HOXA5 a Novel Prognostic Biomarker for Uterine Corpus Endometrioid Adenocarcinoma?
Song C; Kim KB; Lee GS; Shin S; Kim B
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834206
[TBL] [Abstract][Full Text] [Related]
13. [Role of homeobox gene A5 in multidrug resistance of human small cell lung cancer cells].
Xiao F; Chen Z; Zeng X; Bai Y; Guo L; Li Y
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1665-8. PubMed ID: 24273274
[TBL] [Abstract][Full Text] [Related]
14. HINT1 (Histidine Triad Nucleotide-Binding Protein 1) Attenuates Cardiac Hypertrophy Via Suppressing HOXA5 (Homeobox A5) Expression.
Zhang Y; Da Q; Cao S; Yan K; Shi Z; Miao Q; Li C; Hu L; Sun S; Wu W; Wu L; Chen F; Wang L; Gao Y; Huang Z; Shao Y; Chen H; Wei Y; Chen F; Han Y; Xie L; Ji Y
Circulation; 2021 Aug; 144(8):638-654. PubMed ID: 34098726
[TBL] [Abstract][Full Text] [Related]
15. Expression of tumor suppressor genes related to the cell cycle in endometrial cancer patients.
Witek Ł; Janikowski T; Bodzek P; Olejek A; Mazurek U
Adv Med Sci; 2016 Sep; 61(2):317-324. PubMed ID: 27218895
[TBL] [Abstract][Full Text] [Related]
16. WNT5A gene and protein expression in endometrial cancer.
Wasniewski T; Kiezun J; Krazinski BE; Kowalczyk AE; Szostak B; Wierzbicki PM; Kiewisz J
Folia Histochem Cytobiol; 2019; 57(2):84-93. PubMed ID: 31198984
[TBL] [Abstract][Full Text] [Related]
17. Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Sakaguchi H; Tamaya T
Oncol Rep; 2007 Feb; 17(2):345-50. PubMed ID: 17203172
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-1 and -2 messenger RNA expression in normal and neoplastic endometrial tissues: correlation with angiogenesis and prognosis.
Seki N; Kodama J; Hashimoto I; Hongo A; Yoshinouchi M; Kudo T
Int J Oncol; 2001 Aug; 19(2):305-10. PubMed ID: 11445843
[TBL] [Abstract][Full Text] [Related]
19. Expression of basic fibroblast growth factor and its mRNA in uterine endometrial cancers.
Fujimoto J; Hori M; Ichigo S; Tamaya T
Invasion Metastasis; 1995; 15(5-6):203-10. PubMed ID: 8765195
[TBL] [Abstract][Full Text] [Related]
20. Expressions of vascular endothelial growth factor (VEGF) and its mRNA in uterine endometrial cancers.
Fujimoto J; Ichigo S; Hirose R; Sakaguchi H; Tamaya T
Cancer Lett; 1998 Dec; 134(1):15-22. PubMed ID: 10381125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
